Needham & Co initiates coverage on Gilead Sciences Inc. (Nasdaq: GILD) with a Buy. Price target $51.

This article: 144 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE